SITAGLIPTIN/METFORMIN SANDOZ XR 100/1000 sitagliptin (as hydrochloride monohydrate)/metformin hydrochloride 100 mg/1000 mg extended release tablet bottle

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Toimeaine:

sitagliptin hydrochloride monohydrate, Quantity: 113.37 mg (Equivalent: sitagliptin, Qty 100 mg); metformin hydrochloride, Quantity: 1000 mg

Saadav alates:

Sandoz Pty Ltd

Ravimvorm:

Tablet, modified release

Koostis:

Excipient Ingredients: povidone; hypromellose; hyprolose; titanium dioxide; purified talc; macrogol 3350; propyl gallate; sodium stearylfumarate; indigo carmine aluminium lake; colloidal anhydrous silica

Manustamisviis:

Oral

Ühikuid pakis:

56, 260, 28

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

Sitagliptin/Metformin Sandoz XR (sitagliptin hydrochloride monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.,[see Section 5.1 Pharmacodynamic properties, Clinical trials and 4.2 Dose and method of administration].

Toote kokkuvõte:

Visual Identification: Blue, bi-convex, oval tablets.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Volitamisolek:

Registered

Loa andmise kuupäev:

2023-05-19